🧑⚖️ Eli Lilly is having a rough time in the courts
Lawsuits just aren't going the way of the pharmaceutical giant
The lawsuits really started flying after the compounding restrictions came into play — many compounding pharmacies fought to keep the ability to compound Tirzepatide (and Semaglutide) when they came out of shortage.
While compounding is long gone, the legal battles still continue, they’re just mostly not about compounding.
In this edition we take a quick look at how Eli Lilly has been doing in some recent suits (hint: it’s not good).
For the average person this won’t affect GLP1 availability either way (those who have found work-arounds use them, and others buy direct or use Insurace), but these cases might create large savings for the state (and medicaid):